You have no items in your cart.
Long-term Treatment With Enjaymo Safe and Effective, Trial Data Show
Cold Agglutinin News
Long-term treatment with Sanofi’s Enjaymo (sutimlimab-jome) safely and effectively prevented red blood cell destruction (hemolysis), anemia, and the need for blood transfusions, while improving the quality of life in adults ... Read more